PBM Formulary Exclusions In Oncology Are On The Rise
Physician-Administered Drugs Make Up Nearly Half Of Oncology Exclusions
Executive Summary
Oncology drugs are no longer immune to pharmacy benefit management formulary exclusions in the commercial market and even drugs administered in a physician’s office are increasingly being subjected to rebate-driven coverage decisions.